No Additional Information
Vogli is an anti diabetic medication that contains Voglibose as the active ingredient which belongs to class of competitive α glucosisade inhibitors (α-GIs). It works by slowing down the digestion and absorption of glucose in the small intestine. This prevents blood glucose from rising very high after meals.
The anti-hypoglycaemic action of voglibose results from a reversible inhibition of membrane bound intestines α glycosidase hydrolize enzymes which hydrolize oligosaccharides and disaccharides to glucose and other monosaccharides in the brush border of the small intestine.
Thus, voglibose delays the absorption as well as digestion of dietary polysaccharides by reversibly inhibiting carbohydrate digestive enzymes like sucrose, maltose, zomaltase, etc.
Vogli 0.2 mg Tablet is used in the treatment of type 2 diabetes. It is used in addition to diet and exercise to improve blood sugar control in adults with type 2 diabetes.
Direction to Use
Common Side Effects of Vogli are Skin rash, Flatulence, Abdominal pain, Diarrhoea.